Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VE800
VE800
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Pharmaceutical Business Review
Wed, 12/11/19 - 10:10 am
Vedanta Biosciences
VE800
Bristol-Myers Squibb
Opdivo
cancer
clinical trials
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
CP Wire
Thu, 01/24/19 - 10:46 am
Vedanta Biosciences
VE800
immuno-oncology
microbiome
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
Thu, 01/24/19 - 12:19 am
Vedanta Biosciences
VE800
immuno-oncology
microbiome
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
CP WIre
Mon, 12/10/18 - 11:35 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
micro
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
Mon, 12/10/18 - 11:34 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
microbiome
Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate
CP Wire
Wed, 11/7/18 - 11:23 pm
Vedanta Biosciences
microbiome
VE800